Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes.
about
Hepatotoxicity of targeted therapy for cancer.The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.Ameliorative Effect of Gallic Acid in Doxorubicin-Induced Hepatotoxicity in Wistar Rats Through Antioxidant Defense System.The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling.
P2860
Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@ast
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@en
type
label
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@ast
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@en
prefLabel
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@ast
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@en
P2093
P2860
P356
P1433
P1476
Lapatinib promotes the inciden ...... t accumulation in hepatocytes.
@en
P2093
ChunLing Dai
HongYun Zhao
Kenneth To
ShaoLin Ma
XingPing Wu
ZheSheng Chen
ZhenCong Huang
P2860
P304
17738-17752
P356
10.18632/ONCOTARGET.3921
P407
P577
2015-07-01T00:00:00Z